Prosecution Insights
Last updated: September 17, 2026
Application No. 18/014,124

METHOD AND SYSTEM FOR DETERMINING PHASE TRANSITION IN YOUNG ANIMAL

Non-Final OA §101
Filed
Dec 30, 2022
Priority
Jul 03, 2020 — NL 2025991 +1 more
Examiner
FUELLING, MICHAEL
Art Unit
Tech Center
Assignee
Nedap N V
OA Round
2 (Non-Final)
44%
Grant Probability
Moderate
2-3
OA Rounds
6m
Est. Remaining
75%
With Interview

Examiner Intelligence

Grants 44% of resolved cases
44%
Career Allowance Rate
86 granted / 197 resolved
-16.3% vs TC avg
Strong +31% interview lift
Without
With
+31.1%
Interview Lift
resolved cases with interview
Typical timeline
4y 2m
Avg Prosecution
14 currently pending
Career history
202
Total Applications
across all art units

Statute-Specific Performance

§101
22.8%
-17.2% vs TC avg
§103
35.8%
-4.2% vs TC avg
§102
10.0%
-30.0% vs TC avg
§112
25.5%
-14.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 197 resolved cases

Office Action

§101
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-23 are rejected under 35 USC 101. Step 2A, Prong One Claims 1–19 and 21–23 are directed to a judicial exception, namely an abstract idea of organizing human activity and/or a mathematical relationship. More particularly, the claims recite collecting information, 1 analyzing the collected information, and determining a result based on the analysis. The claimed method includes measuring one or more body or behavior parameters of a young animal, receiving measuring values, processing the measuring values, and detecting a phase transition or determining an extent of attention to solid food. Such activities are directed to data gathering and evaluation, which are concepts that can be performed mentally or with the aid of generic tools and therefore recite an abstract idea. Claim 20, although recited as a system, is likewise directed to the same abstract idea. The system claim recites a plurality of measuring instruments and a controller configured to receive measuring values and detect a phase transition based on those values. The recited system elements are generic components used to perform routine sensing and analysis functions. Accordingly, claim 20 also recites an abstract idea. Step 2A, Prong Two The claims do not integrate the abstract idea into a practical application. Although the claims recite a measuring instrument, a controller, and in some instances a data processing model, these additional elements are recited at a high level of generality and do not impose any meaningful limit on the abstract idea. The claims do not recite an improvement in the functioning of a computer, a particular machine integral to the performance of the claimed method, or a transformation of an article into a different state or thing. Rather, the additional elements are merely used as tools to gather, process, and analyze information about the young animal. The recited limitations relating to, for example body or behavior parameters, regression models, fields of interest, and stress condition do not alter the fundamental character of the claims. These features amount to field-of-use limitations, data sources, or outputs of the abstract analysis, and therefore do not amount to a practical application. Accordingly, claims 1–23 fail to integrate the judicial exception into a practical application. Step 2B The claims also do not recite additional elements that amount to significantly more than the judicial exception. The measuring instruments, controller, and data processing model are recited generically and perform only routine and conventional functions of measuring, receiving, processing, and outputting information. The claimed use of a self-learning data processing model, including neural network, random forest, or regression-based implementations, does not, by itself, add an inventive concept. The claims do not recite a particular improvement in computer functionality or a non-conventional arrangement of components. Instead, they apply known data-processing techniques to the field of animal monitoring. The additional limitations in claims 21–23 also do not add significantly more. Claim 21 merely provides examples of fields of interest. Claim 22 merely narrows the regression model to conventional linear or nonlinear regression models. Claim 23 merely identifies stress as a type of state of health. These recitations do not amount to more than insignificant extra-solution activity or well-understood, routine, and conventional activity. Claim 20 similarly recites only generic measuring instruments and a controller configured to receive data and decide based on that data. The system claim therefore also fails to add significantly more than the abstract idea itself. For these reasons, claims 1–23 are directed to a judicial exception without significantly more and are therefore not patent eligible under 35 U.S.C. § 101. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to MICHAEL FUELLING whose telephone number is (571)270-1367. The examiner can normally be reached hoteling. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MICHAEL FUELLING/ Supervisory Patent Examiner 1 The recitation of a measuring instrument “attached to the young animal or introduced into the young animal” narrows the claim to direct animal-associated sensing and does not appear to encompass embodiments in which measurement is obtained solely through remote monitoring from an external location.
Read full office action

Prosecution Timeline

Dec 30, 2022
Application Filed
May 05, 2026
Non-Final Rejection mailed — §101
Aug 04, 2026
Response Filed
Aug 21, 2026
Non-Final Rejection mailed — §101 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12727792
NON-INVASIVE BLOOD GLUCOSE MONITORING DEVICE AND MANUFACTURING METHOD THEREOF
2y 2m to grant Granted Sep 08, 2026
Patent 12721559
PHYSICOCHEMICAL-SENSING ELECTRONIC SKIN FOR STRESS RESPONSE MONITORING
2y 2m to grant Granted Sep 01, 2026
Patent 12694987
METHOD OF ESTIMATING GLUCOSE METABOLIC CAPACITY
2y 1m to grant Granted Jul 28, 2026
Patent 12646125
COMPUTER SYSTEMS, METHODS, AND NON-TRANSITORY COMPUTER-READABLE STORAGE DEVICES FOR OPTIMAL HOME RENTALS
1y 9m to grant Granted Jun 02, 2026
Patent 9218592
COMPUTER SYSTEM AND METHOD FOR PROCESSING DATA RELATING TO NURSE INTERVENTION PROGRAM DECISIONS
2y 3m to grant Granted Dec 22, 2015
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3
Expected OA Rounds
44%
Grant Probability
75%
With Interview (+31.1%)
4y 2m (~6m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 197 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month